Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Sang Joon Lee | Researchclopedia

Back to researchers

Sang Joon Lee

Kosin University ORCID

65

Works

3,300

Citations

26

h-index

37

i10-index

Research Topics

Biosimilars and Bioanalytical Methods Rheumatoid Arthritis Research and Therapies Monoclonal and Polyclonal Antibodies Research

Affiliations

University of New Mexico2013–2013

Seoul National University Hospital2021–2021

Kyung Hee University2021–2021

Chong Kun Dang Bio (South Korea)2000–2005

Korea Institute of Toxicology2014–2014

Top Works

A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study

Dae‐Hyun Yoo,Paweł Hrycaj,et al.

2013651 citations

Pharmaceutical studies and practices

Health Systems, Economic Evaluations, Quality of Life

A randomised, double-blind, multicentre, parallel-group, prospective study comparing the pharmacokinetics, safety, and efficacy of CT-P13 and innovator infliximab in patients with ankylosing spondylitis: the PLANETAS study

Won Park,Paweł Hrycaj,et al.

2013602 citations

Efficacy and safety of switching from reference infliximab to CT-P13 compared with maintenance of CT-P13 in ankylosing spondylitis: 102-week data from the PLANETAS extension study

Won Park,Dae‐Hyun Yoo,et al.

2016227 citations

Randomized Controlled Trial: Subcutaneous vs Intravenous Infliximab CT-P13 Maintenance in Inflammatory Bowel Disease

Stefan Schreiber,Shomron Ben‐Horin,et al.

2021221 citations

Efficacy and safety of biosimilar CT-P13 compared with originator infliximab in patients with active Crohn's disease: an international, randomised, double-blind, phase 3 non-inferiority study

Byong Duk Ye,Marina Pesegova,et al.

2019204 citations

CT-P6 compared with reference trastuzumab for HER2-positive breast cancer: a randomised, double-blind, active-controlled, phase 3 equivalence trial

Justin Stebbing,Y. Baranau,et al.

2017121 citations

Post-marketing study of biosimilar infliximab (CT-P13) to evaluate its safety and efficacy in Korea

Sang Hyoung Park,Young Ho Kim,et al.

2015111 citations

Evaluation of the pharmacokinetic equivalence and 54-week efficacy and safety of CT-P13 and innovator infliximab in Japanese patients with rheumatoid arthritis

Tsutomu Takeuchi,Hisashi Yamanaka,et al.

201581 citations

A multicentre randomised controlled trial to compare the pharmacokinetics, efficacy and safety of CT-P10 and innovator rituximab in patients with rheumatoid arthritis

Dae‐Hyun Yoo,Chang‐Hee Suh,et al.

201681 citations